A detailed history of Dupree Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Dupree Financial Group, LLC holds 551 shares of LLY stock, worth $417,404. This represents 0.2% of its overall portfolio holdings.

Number of Shares
551
Previous 551 -0.0%
Holding current value
$417,404
Previous $499 Million 2.15%
% of portfolio
0.2%
Previous 0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $289,379 - $341,140
551 New
551 $321 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $720B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dupree Financial Group, LLC Portfolio

Follow Dupree Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupree Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dupree Financial Group, LLC with notifications on news.